Replies to post #10386 on Biotech Values

[randychub]

so your advising to stay away even with this drop? Thats what I'll be doing. My gut tells me to buy. lol

R

[DewDiligence]

MATK is an example of what happens when a company priced for perfection is far from perfect: it’s down about 60% in six months. Please see #msg-6171835 for a refresher course.

I think MATK needs a new CEO with some credibility on Wall Street—something quite a few biotechs could use, actually.